Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/84935
Full metadata record
DC FieldValueLanguage
dc.creatorFrancisco D. C. Guerra Liberal
dc.creatorAdriana Alexandre S. Tavares
dc.creatorJoão Manuel R. S. Tavares
dc.date.accessioned2019-02-06T16:01:45Z-
dc.date.available2019-02-06T16:01:45Z-
dc.date.issued2016
dc.identifier.issn0969-8043
dc.identifier.othersigarra:108862
dc.identifier.urihttps://repositorio-aberto.up.pt/handle/10216/84935-
dc.description.abstractPurposeThe present review article aims to provide an overview of the available radionuclides for palliative treatment of bone metastases beyond 89Sr and 153Sm. In addition, it aims to review and summarize the clinical outcomes associated with the palliative treatment of bone metastases using different radiopharmaceuticals.Materials and methodsA literature search was conducted on Science Direct and PubMed databases (1990 - 2015). The following search terms were combined in order to obtain relevant results: bone, metastases, palliative, care, therapy, treatment, radiotherapy, review, radiopharmaceutical, phosphorus-32, strontium-89, yttrium-90, tin-117m, samarium-153, holmium-166, thulium-170, lutetium-177, rhenium-186, rhenium-188 and radium-223. Studies were included if they provided information regarding the clinical outcomes.Results and conclusionsA comparative analysis of the measured therapeutic response of different radiopharmaceuticals, based on previously published data, suggests that there is a lack of substantial differences in palliative efficacy among radiopharmaceuticals. However, when the comparative analysis adds factors such as patients life expectancy, radionuclides physical characteristics (e.g. tissue penetration range and half-life) and health economics to guide the rational selection of a radiopharmaceutical for palliative treatment of bone metastases, 177Lu and 188Re-labeled radiopharmaceuticals appear to be the most suitable radiopharmaceuticals for treatment of small and medium/large size bone lesions, respectively.
dc.language.isoeng
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCiências Tecnológicas, Ciências médicas e da saúde
dc.subjectTechnological sciences, Medical and Health sciences
dc.titlePalliative treatment of metastatic bone pain with radiopharmaceuticals: a perspective beyond Strontium-89 and Samarium-153
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Engenharia
dc.identifier.doi10.1016/j.apradiso.2016.01.003
dc.subject.fosCiências médicas e da saúde
dc.subject.fosMedical and Health sciences
Appears in Collections:FEUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
108862.pdfPaper1.19 MBAdobe PDFThumbnail
View/Open
108862.1.png1st Page180.38 kBimage/pngThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons